Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/09/uipath-path-stock-sinks-as-traders-question-ai-growth-story.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

UiPath PATH Stock Sinks As Traders Question AI Growth Story

TIM BOHENUPDATED SEP. 16, 2026, 4:47 PM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

UiPath Inc. stocks have been trading down by -3.87 percent after cautious sentiment over automation demand and valuation pressures.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading PATH

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways For UiPath PATH Traders

  • UiPath stock fell between 11% and 17% after its latest quarterly results, signaling a sharply negative market reaction and shaking confidence in the near-term trend.
  • BofA raised its UiPath PATH price target from $13 to $15 but kept an Underperform rating, doubting whether AI will truly speed up ARR growth.
  • RBC flagged UiPath PATH as part of a weaker application software group, as AI spending shifts toward cyber, infrastructure, and data platforms.
  • Insider selling from UiPath CEO Daniel Dines, who unloaded about 1.4 million shares worth roughly $22.5M, adds another caution flag for PATH traders.

Candlestick Chart

Live Update At 16:46:45 EDT: On Wednesday, September 16, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -3.87%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

UiPath PATH is trading like a name coming off a bad earnings hangover. Over the last few weeks, PATH slid from the high $18s on 2026/08/31 to around $13.63 on 2026/09/16. That is a steep downtrend, and it tells traders the market is re-pricing the entire UiPath story.

Despite the pain, the underlying business is not tiny or broken. UiPath reported about $1.61B in annual revenue, with revenue still growing double digits over three and five years. Gross margin sits near 83%, which is strong for a software automation platform. PATH also posted a recent quarter with $410.26M in revenue and $36.09M in net income, translating into a positive earnings print and free cash flow near $29.31M.

On the balance sheet, UiPath carries minimal debt, a total debt-to-equity ratio near 0.04, and a current ratio around 2.3. That means PATH has plenty of liquidity to keep operating through rough patches. The valuation, with a price-to-sales near 4.6 and a P/E just above 24, now reflects slower growth expectations. For active traders, that sets up a battleground: strong margins and cash versus a sliding chart and shaken sentiment.

More Breaking News

Intraday, PATH’s 5‑minute chart around $13.6 shows tight trading ranges and fading volatility late in the day, signaling consolidation after heavy selling pressure.

Why Traders Are Watching PATH After The Earnings Drop

UiPath PATH is in the middle of a real sentiment reset. The stock plunged roughly 16%–17% following its latest quarterly earnings release, with several reports pegging the initial hit at about 11% in early trading and deepening into the mid‑teens by the close on 2026/09/04. For a widely followed AI automation name, that is not just noise. That is a full repricing.

Traders are asking a simple question: is this just an overreaction, or has the growth story truly cooled? Wall Street is not giving PATH a clear vote of confidence. Bank of America nudged its UiPath PATH price target up from $13 to $15, but it kept an Underperform rating even after the selloff. That combination says a lot. BofA is willing to acknowledge slightly better margin assumptions, but it still doubts that UiPath’s AI push will meaningfully accelerate annual recurring revenue any time soon.

RBC adds more pressure. Its latest note lumps UiPath PATH in with other application-focused software names, pointing out that this whole bucket is now dragging down beat magnitude and lagging behind hotter AI areas like cyber, infrastructure, and data. In plain English, spending is rotating toward the plumbing of AI, not the front-end apps. That backdrop makes it tougher for PATH to reclaim its old multiple quickly.

Layer on top the insider activity: UiPath CEO Daniel Dines recently sold about 1.4M shares, worth roughly $22.5M. He still controls around 26.5M Class A shares, so he remains heavily aligned with UiPath PATH. But in the short term, traders hate seeing big insider sales right after a weak quarter. It feeds the bearish narrative and can cap bounces.

For day traders and swing traders, this mix of a broken chart, cautious analysts, and sector headwinds keeps PATH firmly on the watchlist.

Conclusion

For active traders, UiPath PATH now sits at the intersection of solid fundamentals and bruised expectations. The company is generating over $400M in quarterly revenue, throwing off positive earnings and free cash flow, and running with high gross margins and low debt. On paper, that is a quality software business. But the tape does not lie. A 16%–17% post‑earnings flush, followed by a slide from near $18 to the low‑$13s, tells you big money is re‑rating UiPath PATH’s AI growth story.

BofA’s Underperform stance, even with a slightly higher $15 target, and RBC’s concern about application software underperforming other AI groups, keep a lid on enthusiasm. UiPath PATH sits in a part of the market that is no longer the “hot money” AI trade. Traders need to respect that.

For those studying this name, the playbook is discipline. PATH is now a classic case study in how strong stories can collide with hard numbers and shifting narratives. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only the price action and the rules you follow.” In the same spirit of rule‑based trading, As Tim Bohen, lead trainer with StocksToTrade says, “The best trades are the ones you can make without emotion. Plan it, then execute it as if it’s routine.”. UiPath PATH will offer opportunities, but only for traders who stay patient, cut losses fast, and let the chart — not the hype — lead the way.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders